{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:28:12Z","timestamp":1788323292242,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,6]]},"DOI":"10.7759\/cureus.70958","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T03:08:14Z","timestamp":1728270494000},"source":"Crossref","is-referenced-by-count":4,"title":["Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications"],"prefix":"10.7759","author":[{"given":"Gabriela D","family":"Brice\u00f1o Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem  D","family":"Thomas Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrachya","family":"Ajamyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Shekhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Jesus","family":"Avalos Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Flores Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda M","family":"Rayon Rayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmr046","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Meyer ML","year":"2012","unstructured":"Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012, 18:112-26. 10.1093\/humupd\/dmr046","journal-title":"Hum Reprod Update"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurox.2019.100060","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article","volume":"3","author":"Ajmal N","year":"2019","unstructured":"Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article. Eur J Obstet Gynecol Reprod Biol X. 2019, 3:100060. 10.1016\/j.eurox.2019.100060","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan MJ","year":"2019","unstructured":"Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019, 12:249-60. 10.2147\/TACG.S200341","journal-title":"Appl Clin Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185915","article-title":"Do GLP-1 analogs have a place in the treatment of PCOS? New insights and promising therapies","volume":"12","author":"Szczesnowicz A","year":"2023","unstructured":"Szczesnowicz A, Szeliga A, Niwczyk O, Bala G, Meczekalski B. Do GLP-1 analogs have a place in the treatment of PCOS? New insights and promising therapies. J Clin Med. 2023, 12:5915. 10.3390\/jcm12185915","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.110759","article-title":"Polycystic ovarian syndrome","volume":"79","author":"Madnani N","year":"2013","unstructured":"Madnani N, Khan K, Chauhan P, Parmar G. Polycystic ovarian syndrome. Indian J Dermatol Venereol Leprol. 2013, 79:310-21. 10.4103\/0378-6323.110759","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajum.12096","article-title":"Rotterdam criteria, the end","volume":"21","author":"Smet ME","year":"2018","unstructured":"Smet ME, McLennan A. Rotterdam criteria, the end. Australas J Ultrasound Med. 2018, 21:59-60. 10.1002\/ajum.12096","journal-title":"Australas J Ultrasound Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.157780","article-title":"Exposure to multiple toxic metals and polycystic ovary syndrome risk: endocrine disrupting effect from As, Pb and Ba","volume":"849","author":"Liang C","year":"2022","unstructured":"Liang C, Zhang Z, Cao Y, et al.. Exposure to multiple toxic metals and polycystic ovary syndrome risk: endocrine disrupting effect from As, Pb and Ba. Sci Total Environ. 2022, 849:157780. 10.1016\/j.scitotenv.2022.157780","journal-title":"Sci Total Environ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49177","article-title":"Maternal exposure to arsenic and its impact on maternal and fetal health: a review","volume":"15","author":"Ortiz-Garcia NY","year":"2023","unstructured":"Ortiz-Garcia NY, Cipriano Ram\u00edrez AI, Juarez K, Brand Galindo J, Brice\u00f1o G, Calderon Martinez E. Maternal exposure to arsenic and its impact on maternal and fetal health: a review. Cureus. 2023, 15:e49177. 10.7759\/cureus.49177","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab134","article-title":"Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome","volume":"106","author":"Joham AE","year":"2021","unstructured":"Joham AE, Kakoly NS, Teede HJ, Earnest A. Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2021, 106:1585-93. 10.1210\/clinem\/dgab134","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.29063\/ajrh2023\/v27i6.5","article-title":"Risk factors for polycystic ovary syndrome among women of reproductive age in Egypt: a case control study","volume":"27","author":"Ibrahim AA","year":"2023","unstructured":"Ibrahim AA, Mohammed HS, Elsaid NM, Salim AA, Fathy EG, Hasaneen NM. Risk factors for polycystic ovary syndrome among women of reproductive age in Egypt: a case control study. Afr J Reprod Health. 2023, 27:41-50. 10.29063\/ajrh2023\/v27i6.5","journal-title":"Afr J Reprod Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25076","article-title":"Cardio-metabolic disease and polycystic ovarian syndrome (PCOS): a narrative review","volume":"14","author":"Sangaraju SL","year":"2022","unstructured":"Sangaraju SL, Yepez D, Grandes XA, Talanki Manjunatha R, Habib S. Cardio-metabolic disease and polycystic ovarian syndrome (PCOS): a narrative review. Cureus. 2022, 14:e25076. 10.7759\/cureus.25076","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1573402115666190531071422","article-title":"Hypertension in polycystic ovary syndrome: novel insights","volume":"16","author":"Macut D","year":"2020","unstructured":"Macut D, Mladenovi\u0107 V, Bjeki\u0107-Macut J, et al.. Hypertension in polycystic ovary syndrome: novel insights. Curr Hypertens Rev. 2020, 16:55-60. 10.2174\/1573402115666190531071422","journal-title":"Curr Hypertens Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo JC","year":"2006","unstructured":"Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91:1357-63. 10.1210\/jc.2005-2430","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","article-title":"Endocrine and metabolic characteristics in polycystic ovary syndrome","volume":"63","author":"Glintborg D","year":"2016","unstructured":"Glintborg D. Endocrine and metabolic characteristics in polycystic ovary syndrome. Dan Med J. 2016, 63:B5232.","journal-title":"Dan Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag G","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016, 31:2841-55. 10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun O","year":"2020","unstructured":"Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020, 30:399-404. 10.1016\/j.tcm.2019.08.010","journal-title":"Trends Cardiovasc Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.01.003","article-title":"Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype","volume":"216","author":"Engmann L","year":"2017","unstructured":"Engmann L, Jin S, Sun F, et al.. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. Am J Obstet Gynecol. 2017, 216:493.e1-13. 10.1016\/j.ajog.2017.01.003","journal-title":"Am J Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein IF","year":"1935","unstructured":"Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935, 29:181-91. 10.1016\/S0002-9378(15)30642-6","journal-title":"Am J Obstet Gynecol"},{"key":"ref19","unstructured":"Evidence-based methodology workshop on polycystic ovary syndrome (PCOS). (2024). Accessed. 2024: https:\/\/prevention.nih.gov\/research-priorities\/research-needs-and-gaps\/pathways-prevention\/evidence-based-methodology...."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19.41-7. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi MO","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7:219-31. 10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede HJ","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al.. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018, 33:1602-18. 10.1093\/humrep\/dey256","journal-title":"Hum Reprod"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2024.05.163","article-title":"Anti-M\u00fcllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis","volume":"122","author":"van der Ham K","year":"2024","unstructured":"van der Ham K, Laven JS, Tay CT, Mousa A, Teede H, Louwers YV. Anti-M\u00fcllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. Fertil Steril. 2024, 122:727-39. 10.1016\/j.fertnstert.2024.05.163","journal-title":"Fertil Steril"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019, 3:1545-73. 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede HJ","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJ, et al.. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023, 108:2447-69. 10.1210\/clinem\/dgad463","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \"risk-enhancing\" factor for cardiovascular disease","volume":"117","author":"Guan C","year":"2022","unstructured":"Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, Michos ED. Polycystic ovary syndrome: a \"risk-enhancing\" factor for cardiovascular disease. Fertil Steril. 2022, 117:924-35. 10.1016\/j.fertnstert.2022.03.009","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12487","article-title":"Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research","volume":"21","author":"Harada M","year":"2022","unstructured":"Harada M. Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research. Reprod Med Biol. 2022, 21:e12487. 10.1002\/rmb2.12487","journal-title":"Reprod Med Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.231251","article-title":"Diagnosis and management of polycystic ovarian syndrome","volume":"196","author":"Dason ES","year":"2024","unstructured":"Dason ES, Koshkina O, Chan C, Sobel M. Diagnosis and management of polycystic ovarian syndrome. CMAJ. 2024, 196:E85-94. 10.1503\/cmaj.231251","journal-title":"CMAJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9240569","article-title":"Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature","volume":"2022","author":"Xu Y","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022, 2022:9240569. 10.1155\/2022\/9240569","journal-title":"J Healthc Eng"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp024","article-title":"Visually scoring hirsutism","volume":"16","author":"Yildiz BO","year":"2010","unstructured":"Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010, 16:51-64. 10.1093\/humupd\/dmp024","journal-title":"Hum Reprod Update"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen MJ","year":"2007","unstructured":"Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension. 2007, 49:1442-7. 10.1161\/HYPERTENSIONAHA.106.083972","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.33588\/fem.263.1279","article-title":"Reflections on the design of an ultrasound study program in medical undergraduate","volume":"26","author":"Calder\u00f3n-Mart\u00ednez E","year":"2023","unstructured":"Calder\u00f3n-Mart\u00ednez E, Pe\u00f1a-Carranza R, Sampieri-Cabrera R. Reflections on the design of an ultrasound study program in medical undergraduate. Revista de la Fundaci\u00f3n Educaci\u00f3n M\u00e9dica. 2023, 26:93-9. 10.33588\/fem.263.1279","journal-title":"Revista de la Fundaci\u00f3n Educaci\u00f3n M\u00e9dica"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14710","article-title":"Approach to androgen excess in women: clinical and biochemical insights","volume":"97","author":"Cussen L","year":"2022","unstructured":"Cussen L, McDonnell T, Bennett G, Thompson CJ, Sherlock M, O'Reilly MW. Approach to androgen excess in women: clinical and biochemical insights. Clin Endocrinol (Oxf). 2022, 97:174-86. 10.1111\/cen.14710","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.14194.48320","article-title":"Ultrasonograf\u00eda did\u00e1ctica para profesores de pregrado mediante herramientas virtuales [Article in Spanish]","author":"Sampieri-Cabrera R","year":"2023","unstructured":"Sampieri-Cabrera R, Calderon-Martinez E. Ultrasonograf\u00eda did\u00e1ctica para profesores de pregrado mediante herramientas virtuales [In Spanish]. UNAM, Mexico; 2023. 10.13140\/RG.2.2.14194.48320"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-019-09888-z","article-title":"Gender differences in hypertension","volume":"13","author":"Song JJ","year":"2020","unstructured":"Song JJ, Ma Z, Wang J, Chen LX, Zhong JC. Gender differences in hypertension. J Cardiovasc Transl Res. 2020, 13:47-54. 10.1007\/s12265-019-09888-z","journal-title":"J Cardiovasc Transl Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130140","article-title":"Sex and gender differences in control of blood pressure","volume":"125","author":"Maranon R","year":"2013","unstructured":"Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci (Lond). 2013, 125:311-8. 10.1042\/CS20130140","journal-title":"Clin Sci (Lond)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-77932-4_9","article-title":"Sex differences in regulation of blood pressure","volume":"1065","author":"Reckelhoff JF","year":"2018","unstructured":"Reckelhoff JF. Sex differences in regulation of blood pressure. Adv Exp Med Biol. 2018, 1065:139-51. 10.1007\/978-3-319-77932-4_9","journal-title":"Adv Exp Med Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07660","article-title":"Estrogen signaling in the adrenal cortex: implications for blood pressure sex differences","volume":"68","author":"Caroccia B","year":"2016","unstructured":"Caroccia B, Seccia TM, Barton M, Rossi GP. Estrogen signaling in the adrenal cortex: implications for blood pressure sex differences. Hypertension. 2016, 68:840-8. 10.1161\/HYPERTENSIONAHA.116.07660","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.189","article-title":"Sex-specific differences in hypertension and associated cardiovascular disease","volume":"14","author":"Colafella KM","year":"2018","unstructured":"Colafella KM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018, 14:185-201. 10.1038\/nrneph.2017.189","journal-title":"Nat Rev Nephrol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e3283431921","article-title":"Estrogen, hormonal replacement therapy and cardiovascular disease","volume":"20","author":"Yang XP","year":"2011","unstructured":"Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011, 20:133-8. 10.1097\/MNH.0b013e3283431921","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5339\/gcsp.2013.34","article-title":"RAAS inhibition and mortality in hypertension","volume":"2013","author":"Ferrari R","year":"2013","unstructured":"Ferrari R. RAAS inhibition and mortality in hypertension. Glob Cardiol Sci Pract. 2013, 2013:269-78. 10.5339\/gcsp.2013.34","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1080\/gye.16.6.447.452","article-title":"The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS","volume":"16","author":"Uncu G","year":"2002","unstructured":"Uncu G, S\u00f6zer MC, Develio\u011flu O, Cengiz C. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS. Gynecol Endocrinol. 2002, 16:447-52.","journal-title":"Gynecol Endocrinol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5772\/66748","article-title":"Role of the renin-angiotensin system in healthy and pathological pregnancies","author":"Pepin \u00c9","year":"2017","unstructured":"Pepin \u00c9, Dehboneh SS, Raguema N, Esfandarani MT, Lavoie JL. Role of the renin-angiotensin system in healthy and pathological pregnancies. Renin-Angiotensin System - Past, Present and Future. Tolekova AN (ed): IntechOpen, London, England; 2017. 10.5772\/66748"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.088138","article-title":"Polycystic ovary syndrome: androgens and hypertension","volume":"49","author":"Reckelhoff JF","year":"2007","unstructured":"Reckelhoff JF. Polycystic ovary syndrome: androgens and hypertension. Hypertension. 2007, 49:1220-1. 10.1161\/HYPERTENSIONAHA.107.088138","journal-title":"Hypertension"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116672588","article-title":"The ovarian renin-angiotensin system (OVRAS): a major factor in ovarian function and disease","volume":"23","author":"Palumbo A","year":"2016","unstructured":"Palumbo A, \u00c1vila J, Naftolin F. The ovarian renin-angiotensin system (OVRAS): a major factor in ovarian function and disease. Reprod Sci. 2016, 23:1644-55. 10.1177\/1933719116672588","journal-title":"Reprod Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2013.769513","article-title":"Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)","volume":"29","author":"Arefi S","year":"2013","unstructured":"Arefi S, Mottaghi S, Sharifi AM. Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs). Gynecol Endocrinol. 2013, 29:470-3. 10.3109\/09513590.2013.769513","journal-title":"Gynecol Endocrinol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.06.006","article-title":"Altered endothelin expression in granulosa-lutein cells of women with polycystic ovary syndrome","volume":"91","author":"Imbar T","year":"2012","unstructured":"Imbar T, Klipper E, Greenfield C, Hurwitz A, Haimov-Kochman R, Meidan R. Altered endothelin expression in granulosa-lutein cells of women with polycystic ovary syndrome. Life Sci. 2012, 91:703-9. 10.1016\/j.lfs.2012.06.006","journal-title":"Life Sci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1159\/000477572","article-title":"Plasma ET-1 concentrations are elevated in patients with hypertension - meta-analysis of clinical studies","volume":"42","author":"Xu M","year":"2017","unstructured":"Xu M, Lu YP, Hasan AA, Hocher B. Plasma ET-1 concentrations are elevated in patients with hypertension - meta-analysis of clinical studies. Kidney Blood Press Res. 2017, 42:304-13. 10.1159\/000477572","journal-title":"Kidney Blood Press Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642634","article-title":"Association between insulin resistance and cardiovascular risk factors in polycystic ovary syndrome patients","volume":"40","author":"Wanderley MD","year":"2018","unstructured":"Wanderley MD, Pereira LC, Santos CB, Cunha VS, Neves MV. Association between insulin resistance and cardiovascular risk factors in polycystic ovary syndrome patients. Rev Bras Ginecol Obstet. 2018, 40:188-95. 10.1055\/s-0038-1642634","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/786362","article-title":"Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women","volume":"2015","author":"Baldani DP","year":"2015","unstructured":"Baldani DP, Skrgatic L, Ougouag R. Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women. Int J Endocrinol. 2015, 2015:786362. 10.1155\/2015\/786362","journal-title":"Int J Endocrinol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim SS","year":"2013","unstructured":"Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013, 14:95-109. 10.1111\/j.1467-789X.2012.01053.x","journal-title":"Obes Rev"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.574651","article-title":"Hypertension risk in young women with polycystic ovary syndrome: a nationwide population-based cohort study","volume":"7","author":"Wu CH","year":"2020","unstructured":"Wu CH, Chiu LT, Chang YJ, Lee CI, Lee MS, Lee TH, Wei JC. Hypertension risk in young women with polycystic ovary syndrome: a nationwide population-based cohort study. Front Med (Lausanne). 2020, 7:574651. 10.3389\/fmed.2020.574651","journal-title":"Front Med (Lausanne)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.11.034","article-title":"ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome","volume":"111","author":"Marchesan LB","year":"2019","unstructured":"Marchesan LB, Spritzer PM. ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome. Fertil Steril. 2019, 111:579-87.e1. 10.1016\/j.fertnstert.2018.11.034","journal-title":"Fertil Steril"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker V","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, et al.. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020, 26:942-60. 10.1093\/humupd\/dmaa029","journal-title":"Hum Reprod Update"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0527","article-title":"Higher blood pressure in normal weight women with PCOS compared to controls","volume":"10","author":"Mellembakken JR","year":"2021","unstructured":"Mellembakken JR, Mahmoudan A, M\u00f8rkrid L, et al.. Higher blood pressure in normal weight women with PCOS compared to controls. Endocr Connect. 2021, 10:154-63. 10.1530\/EC-20-0527","journal-title":"Endocr Connect"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild RA","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011, 95:1073-9.e1-11. 10.1016\/j.fertnstert.2010.12.027","journal-title":"Fertil Steril"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263312","article-title":"Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women","volume":"17","author":"De Jong KA","year":"2022","unstructured":"De Jong KA, Berisha F, Naderpoor N, et al.. Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women. PLoS One. 2022, 17:e0263312. 10.1371\/journal.pone.0263312","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321402","article-title":"Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer","volume":"332","author":"Jacobson JA","year":"1995","unstructured":"Jacobson JA, Danforth DN, Cowan KH, et al.. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995, 332:907-11. 10.1056\/NEJM199504063321402","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46330","article-title":"Hypertrophic cardiomyopathy diagnosis and treatment in high- and low-income countries: a narrative review","volume":"15","author":"Calderon Martinez E","year":"2023","unstructured":"Calderon Martinez E, Ortiz-Garcia NY, Herrera Hernandez DA, et al.. Hypertrophic cardiomyopathy diagnosis and treatment in high- and low-income countries: a narrative review. Cureus. 2023, 15:e46330. 10.7759\/cureus.46330","journal-title":"Cureus"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1597","article-title":"Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA Women's study","volume":"97","author":"Wang ET","year":"2012","unstructured":"Wang ET, Ku IA, Shah SJ, et al.. Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA Women's study. J Clin Endocrinol Metab. 2012, 97:4656-62. 10.1210\/jc.2012-1597","journal-title":"J Clin Endocrinol Metab"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas J","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, et al.. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014, 2014:719050. 10.1155\/2014\/719050","journal-title":"Int J Reprod Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad465","article-title":"Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"109","author":"Melin J","year":"2024","unstructured":"Melin J, Forslund M, Alesi S, et al.. Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2024, 109:e817-36. 10.1210\/clinem\/dgad465","journal-title":"J Clin Endocrinol Metab"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5587412","article-title":"Increased miR-188-3p in ovarian granulosa cells of patients with polycystic ovary syndrome","volume":"2021","author":"Dai B","year":"2021","unstructured":"Dai B, Jiang J. Increased miR-188-3p in ovarian granulosa cells of patients with polycystic ovary syndrome. Comput Math Methods Med. 2021, 2021:5587412. 10.1155\/2021\/5587412","journal-title":"Comput Math Methods Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.03.008","article-title":"Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial","volume":"30","author":"Asemi Z","year":"2014","unstructured":"Asemi Z, Samimi M, Tabassi Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial. Nutrition. 2014, 30:1287-93. 10.1016\/j.nut.2014.03.008","journal-title":"Nutrition"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day F","year":"2018","unstructured":"Day F, Karaderi T, Jones MR, et al.. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018, 14:e1007813. 10.1371\/journal.pgen.1007813","journal-title":"PLoS Genet"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15730-8","article-title":"Benefits of physical activity on reproductive health functions among polycystic ovarian syndrome women: a systematic review","volume":"23","author":"Butt MS","year":"2023","unstructured":"Butt MS, Saleem J, Zakar R, Aiman S, Khan MZ, Fischer F. Benefits of physical activity on reproductive health functions among polycystic ovarian syndrome women: a systematic review. BMC Public Health. 2023, 23:882. 10.1186\/s12889-023-15730-8","journal-title":"BMC Public Health"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27689","article-title":"Recent advances in the management of polycystic ovary syndrome: a review article","volume":"14","author":"Akre S","year":"2022","unstructured":"Akre S, Sharma K, Chakole S, Wanjari MB. Recent advances in the management of polycystic ovary syndrome: a review article. Cureus. 2022, 14:e27689. 10.7759\/cureus.27689","journal-title":"Cureus"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"Cena H","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. 2020, 105:e2695-709. 10.1210\/clinem\/dgaa285","journal-title":"J Clin Endocrinol Metab"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0161-3","article-title":"Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study","volume":"8","author":"Jensterle M","year":"2015","unstructured":"Jensterle M, Salamun V, Kocjan T, Vrtacnik Bokal E, Janez A. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study. J Ovarian Res. 2015, 8:32. 10.1186\/s13048-015-0161-3","journal-title":"J Ovarian Res"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Fr\u00f8ssing S","year":"2018","unstructured":"Fr\u00f8ssing S, Nylander M, Chabanova E, et al.. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial. Diabetes Obes Metab. 2018, 20:215-8. 10.1111\/dom.13053","journal-title":"Diabetes Obes Metab"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.54097\/d2aatp87","article-title":"Combined oral contraceptives (COCs) management on symptoms of polycystic ovary syndrom: a systematic review","volume":"74","author":"Jia S","year":"2023","unstructured":"Jia S. Combined oral contraceptives (COCs) management on symptoms of polycystic ovary syndrom: a systematic review. Highl Sci Eng Technol. 2023, 74:1532-9. 10.54097\/d2aatp87","journal-title":"Highl Sci Eng Technol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2011.01.009","article-title":"Ovarian hypertension: polycystic ovary syndrome","volume":"40","author":"Bentley-Lewis R","year":"2011","unstructured":"Bentley-Lewis R, Seely E, Dunaif A. Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2011, 40:433-49, ix-x. 10.1016\/j.ecl.2011.01.009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1215430","article-title":"Spironolactone in the treatment of polycystic ovary syndrome","volume":"17","author":"Armanini D","year":"2016","unstructured":"Armanini D, Andrisani A, Bordin L, Sabbadin C. Spironolactone in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother. 2016, 17:1713-5. 10.1080\/14656566.2016.1215430","journal-title":"Expert Opin Pharmacother"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ram\u00edrez M","year":"2018","unstructured":"Luque-Ram\u00edrez M, Nattero-Ch\u00e1vez L, Ortiz Flores AE, Escobar-Morreale HF. Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018, 24:225-41. 10.1093\/humupd\/dmx039","journal-title":"Hum Reprod Update"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15318.1","article-title":"Recent advances in the understanding and management of polycystic ovary syndrome","volume":"8","author":"Rocha AL","year":"2019","unstructured":"Rocha AL, Oliveira FR, Azevedo RC, et al.. Recent advances in the understanding and management of polycystic ovary syndrome. F1000Res. 2019, 8:F1000 Faculty Rev-565. 10.12688\/f1000research.15318.1","journal-title":"F1000Res"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51422","article-title":"Ten steps to conduct a systematic review","volume":"15","author":"Calderon Martinez E","year":"2023","unstructured":"Calderon Martinez E, Flores Vald\u00e9s JR, Castillo JL, et al.. Ten steps to conduct a systematic review. Cureus. 2023, 15:e51422. 10.7759\/cureus.51422","journal-title":"Cureus"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041500","article-title":"Polycystic ovary syndrome: challenges and possible solutions","volume":"12","author":"Che Y","year":"2023","unstructured":"Che Y, Yu J, Li YS, Zhu YC, Tao T. Polycystic ovary syndrome: challenges and possible solutions. J Clin Med. 2023, 12:1500. 10.3390\/jcm12041500","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/298442-polycystic-ovarian-syndrome-exploring-hypertension-and-cardiometabolic-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T03:08:19Z","timestamp":1728270499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/298442-polycystic-ovarian-syndrome-exploring-hypertension-and-cardiometabolic-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,6]]},"references-count":77,"URL":"https:\/\/doi.org\/10.7759\/cureus.70958","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,6]]}}}